Hims & Hers Health (HIMS) Shares Outstanding (2019 - 2026)
Hims & Hers Health's (HIMS) quarterly Shares Outstanding came in at $230.7 million in Q1 2026, up 3.18% year-on-year from $223.6 million in Q1 2025, and up 2653.81% quarter-over-quarter from $8.4 million in Q4 2025.
Hims & Hers Health (HIMS) Shares Outstanding (2019 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Shares Outstanding across 8 years of filings, most recently posting $230.7 million for Q1 2026.
- Shares Outstanding for Q1 2026 came in at $230.7 million, up 3.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $230.7 million (up 3.18% YoY), and the FY2025 annual result was $8.4 million, down 96.21% from the prior year.
- Shares Outstanding came in at $230.7 million for Q1 2026 at Hims & Hers Health, up from $8.4 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $230.7 million in Q1 2026 to a low of $205.9 million in Q1 2022.
- The 5-year median for Shares Outstanding is $214.4 million (2024), against an average of $216.4 million.
- Across the five-year window, Shares Outstanding rose 7.59% in 2022 and sank 96.21% in 2025, its largest moves.
- Hims & Hers Health's Shares Outstanding stood at $208.4 million in 2022, then climbed by 2.42% to $213.5 million in 2023, then grew by 3.45% to $220.8 million in 2024, then tumbled by 96.21% to $8.4 million in 2025, then jumped by 2653.81% to $230.7 million in 2026.
- The last three Shares Outstanding figures came in at $230.7 million (Q1 2026), $8.4 million (Q4 2025), and $227.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.27 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 420.35 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 77.13 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 499.38 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 183.59 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 230.70 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 65.07 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 88.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 230.70 Mn |
| Mar 31, 2026 | 230.70 Mn |
| Mar 31, 2026 | 230.70 Mn |
| Mar 31, 2026 | 230.70 Mn |
| Mar 31, 2026 | 230.70 Mn |
| Mar 31, 2026 | 230.70 Mn |
| Mar 31, 2026 | 230.70 Mn |
| Mar 31, 2026 | 230.70 Mn |
| Dec 31, 2025 | 8.38 Mn |
| Dec 31, 2025 | 227.25 Mn |
| Dec 31, 2025 | 227.25 Mn |
| Dec 31, 2025 | 227.25 Mn |
| Dec 31, 2025 | 227.25 Mn |
| Dec 31, 2025 | 8.38 Mn |
| Dec 31, 2025 | 8.38 Mn |
| Dec 31, 2025 | 8.38 Mn |
| Sep 30, 2025 | 227.50 Mn |
| Sep 30, 2025 | 227.50 Mn |
| Sep 30, 2025 | 227.50 Mn |
| Sep 30, 2025 | 227.50 Mn |